Back
LYFE SCIENCES
Project: HERA
NM_000455.5:c.*16+7C>T
p.?  ·  STK11
ACMG/AMP
Starting
Initialising…
0%
Legacy Engine
Ready
View Legacy →
Classification rationale
1

The STK11 c.*16+7C>T (p.?) variant has been reported in ClinVar as likely benign by two clinical laboratories, and no expert-panel review was identified.

clinvar ↗
2

This variant is present at low frequency in gnomAD, with AF 0.00639% in v2.1 and AF 0.00677% in v4.1; these values remain below the 0.1% PM2 threshold.

gnomad_v2 ↗ gnomad_v4 ↗
3

In silico splice prediction does not support a damaging effect, with SpliceAI showing a maximum delta score of 0.01, consistent with no significant splice impact.

spliceai ↗
Applied criteria
Met
Not met
Not assessed
N/A
Very strong
Strong
Moderate
Supporting
Pathogenic evidence
PVS
PVS1
PS
PS1
PS2
PS3
PS4
PM
PM1
PM2
PM3
PM4
PM5
PM6
PP
PP1
PP2
PP3
PP4
PP5
Benign evidence
BA
BA1
BS
BS1
BS2
BS3
BS4
BP
BP1
BP2
BP3
BP4
BP5
BP6
BP7
PVS1
Rationale
Select a criterion to inspect its explanation.
Evidence used
Gaps remaining
Rule
Publications
Research and evidence
gnomAD v2.1 evidence
v2.1
gnomAD v4.1 evidence
v4.1
01
Population
gnomAD v2.1This variant is present in gnomAD v2.1 (AF= 6.39376e-05; MAF= 0.00639%, 8/125122 alleles, homozygotes = 0) and has highest observed frequency in the African/African American population (AF= 0.000145709; MAF= 0.01457%, 2/13726 alleles, homozygotes = 0); grpmax FAF= 5.434e-05.
gnomAD v4.1This variant is present in gnomAD v4.1 (AF= 6.77486e-05; MAF= 0.00677%, 101/1490806 alleles, homozygotes = 0) and has highest observed frequency in the European (non-Finnish) population (AF= 8.26896e-05; MAF= 0.00827%, 93/1124688 alleles, homozygotes = 0); grpmax FAF= 6.881e-05.
ClinVar evidence
02
ClinVar
This variant has been reported in ClinVar as Likely benign (2 clinical laboratories).
03
Functional
No functional summary recorded.
In silico evidence
04
In silico
SpliceAI predicts no significant splice impact for this variant (max delta score = 0.01).
COSMIC evidence
05
COSMIC
This variant has not previously been reported in somatic cancers (COSMIC).
06
Cancer hotspots
No cancer hotspot summary recorded.